Finance

Beta
Lists
CING:NASDAQ
Cingulate Inc
$5.47
+2.82%
(+0.15) 1D
$5.50
+0.55% (+0.030)
After hours
Closed: Jun 30, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CING...
Open
$5.31
High
$5.58
Low
$5.25
Mkt. cap
73.68M
Avg. vol.
674.69K
Volume
335.66K
52-wk high
$11.89
52-wk low
$3.16
EPS
-$4.33
Beta
-0.85
Shares outstanding
13.47M
No. of employees
14
Open
$5.31
High
$5.58
Low
$5.25
Mkt. cap
73.68M
Avg. vol.
674.69K
Volume
335.66K
52-wk high
$11.89
52-wk low
$3.16
EPS
-$4.33
Beta
-0.85
Shares outstanding
13.47M
No. of employees
14
News stories
From sources across the web
About Cingulate Inc
CEO-
Employees14
Founded2012
HeadquartersKansas City, Kansas, United States
SectorPharmaceutical industry
Analyst ratings
Based on 4 analysts giving stock ratings to CING in the past 3 months
Strong buy
Buy
4
Hold
0
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for CING in the last 3 months.
Highest
Current $5.47
$52.00 (+850.64%)
Average
$22.50 (+311.33%)
Lowest
$8.00 (+46.25%)
Analyst
Recommendation
Action
Price target
Projected
Date
Edward Woo
Ascendiant
Buy
Maintained
$52.00
+850.6%
06/06/2026
Boobalan Pachaiyappan
Roth MKM
Buy
Maintained
$10.00
+82.8%
06/04/2026
Naz Rahman
Maxim Group
Buy
Reiterated
$8.00
+46.3%
06/03/2026
Ram Selvaraju
H.C. Wainwright
Buy
Reiterated
$20.00
+265.6%
05/26/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
2.70M
2.85M
2.00M
2.18M
Cost of revenue
2.70M
2.85M
2.00M
2.18M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.95M
3.15M
3.58M
5.74M
Operating expense
1.95M
3.15M
3.58M
5.74M
Total operating expenses
4.65M
6.00M
5.59M
7.92M
Operating income
-4.65M
-6.00M
-5.59M
-7.92M
Other non operating income
-
-772.17K
-133.99K
-852.03K
EBT including unusual items
-4.79M
-7.34M
-6.27M
-9.31M
EBT excluding unusual items
-4.79M
-7.34M
-6.27M
-9.31M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-4.79M
-7.34M
-6.27M
-9.31M
Net profit margin
-
-
-
-
Earnings per share
-1.09
-1.35
-0.84
-0.95
Interest and investment income
-
-
369.27K
-
Interest expense
-138.76K
-573.06K
-921.92K
-536.84K
Net interest expenses
-138.76K
-573.06K
-552.66K
-536.84K
Depreciation and amortization charges
-
-
-
-
EBITDA
-4.50M
-5.89M
-5.46M
-7.80M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create portfolio
Deep Search
AI content may include mistakes. Learn more